Pharmacokinetic-Pharmacodynamic (PK-PD) Model for Tolvaptan in Patients with Hypervolemic Hyponatremia

被引：0
|
作者：
Van Wart, Scott [1 ]
Shoaf, Susan [2 ]
Mallikaarjun, Suresh [2 ]
Mager, Donald [1 ]
机构：
[1] SUNY Buffalo, Buffalo, NY 14260 USA
[2] Otsuka, Rockville, MD USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-06
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [21] A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships
    Guerrero, Yadir A.
    Desai, Diti
    Sullivan, Connor
    Kindt, Erick
    Spilker, Mary E.
    Maurer, Tristan S.
    Solomon, Deepak E.
    Bartlett, Derek W.
    AAPS JOURNAL, 2020, 22 (02):
  • [22] PHARMACOKINETIC-PHARMACODYNAMIC PARAMETER ESTIMATION: APPLICATION OF GENETIC ALGORITHMS FOR PK-PD PARAMETER ESTIMATION
    Das, Shyam S.
    Bahl, Jyotsna
    Narayanan, Ramamurthi
    DRUG METABOLISM REVIEWS, 2015, 47 : 228 - 229
  • [23] Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
    Venisse, Nicolas
    Peytavin, Gilles
    Bouchet, Stephane
    Gagnieu, Marie-Claude
    Garraffo, Rodolphe
    Guilhaumou, Romain
    Solas, Caroline
    ANTIVIRAL RESEARCH, 2020, 181
  • [24] The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics
    Agoram, Balaji M.
    Martin, Steven W.
    van der Graaf, Piet H.
    DRUG DISCOVERY TODAY, 2007, 12 (23-24) : 1018 - 1024
  • [25] Pharmacokinetic/pharmacodynamic (PK/PD) model for tolvaptan (TOL) in healthy subjects.
    Van Wart, SA
    Cirincione, BB
    Ludwig, EA
    Chen, X
    Shoaf, S
    Grasela, TH
    Mallikaarjun, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P60 - P60
  • [26] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats
    Kobuchi, Shinji
    Katsuyama, Yosuke
    Ito, Yukako
    XENOBIOTICA, 2020, 50 (02) : 146 - 153
  • [27] Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study
    Christian Höcht
    Carla Di Verniero
    Javier A. W. Opezzo
    Guillermo F. Bramuglia
    Carlos A. Taira
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373 : 310 - 318
  • [28] The pharmacokinetic-pharmacodynamic (PK-PD) relationship of pasireotide (SOM230), a novel somatostatin analogue, in patients with acromegaly.
    Lee, Lucy
    Glusman, J.
    Gao, B.
    Buchelt, A.
    Deckert, F.
    Schran, H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1086 - 1086
  • [29] Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats:: a microdialysis study
    Hocht, Christian
    Di Verniero, Carla
    Opezzo, Javier A. W.
    Bramuglia, Guillermo F.
    Taira, Carlos A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (04) : 310 - 318
  • [30] Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective
    Wong, Harvey
    Bohnert, Tonika
    Damian-Lordache, Valeriu
    Gibson, Christopher
    Hsu, Cheng-Pang
    Krishnatry, Anu Shilpa
    Liederer, Bianca M.
    Lin, Jing
    Lu, Qiang
    Mettetal, Jerome T.
    Mudra, Daniel R.
    Nijsen, Marjoleen J. M. A.
    Schroeder, Patricia
    Schuck, Edgar
    Suryawanshi, Satyendra
    Trapa, Patrick
    Tsai, Alice
    Wang, Haiqing
    Wus, Fan
    DRUG DISCOVERY TODAY, 2017, 22 (10) : 1447 - 1459
12345